For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
While significant progress has been made in focusing on patient needs, our experts emphasize that much still needs to be done.
Read moreHealthcare professionals and patients alike are inundated with information—now more than ever, it is crucial to deliver personalized and relevant cont
Read moreJessica McKelvey, Vice President, Growth Strategy, speaks about the challenges faced by pharmaceutical and biotech...
Read more